In 2023, the market size value per capita for penicillins and streptomycins in bulk in Japan stood unchanged at $1.15. The forecast from 2024 to 2028 remains steady at $1.15, indicating no anticipated year-on-year variation. Over a five-year period, the compound annual growth rate (CAGR) is 0%, reflecting no growth in value per capita.

Future trends to watch for include:

Potential shifts in healthcare policies affecting antibiotic demand.
Innovations in antibiotic alternatives or advancements in pharmaceutical technology.
Changes in population health needs or demographics influencing market dynamics.